ATHA
Price
$0.57
Change
+$0.02 (+3.64%)
Updated
Dec 20, 04:59 PM (EDT)
87 days until earnings call
OGEN
Price
$0.35
Change
-$0.01 (-2.78%)
Updated
Dec 23, 11:40 AM (EDT)
Ad is loading...

ATHA vs OGEN

Header iconATHA vs OGEN Comparison
Open Charts ATHA vs OGENBanner chart's image
Athira Pharma
Price$0.57
Change+$0.02 (+3.64%)
Volume$836
CapitalizationN/A
Oragenics
Price$0.35
Change-$0.01 (-2.78%)
Volume$300
CapitalizationN/A
ATHA vs OGEN Comparison Chart
Loading...
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATHA vs. OGEN commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHA is a Hold and OGEN is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (ATHA: $0.58 vs. OGEN: $0.36)
Brand notoriety: ATHA and OGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHA: 4% vs. OGEN: 146%
Market capitalization -- ATHA: $22.27M vs. OGEN: $4.35M
ATHA [@Biotechnology] is valued at $22.27M. OGEN’s [@Biotechnology] market capitalization is $4.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHA’s FA Score shows that 1 FA rating(s) are green whileOGEN’s FA Score has 0 green FA rating(s).

  • ATHA’s FA Score: 1 green, 4 red.
  • OGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATHA and OGEN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHA’s TA Score shows that 3 TA indicator(s) are bullish while OGEN’s TA Score has 4 bullish TA indicator(s).

  • ATHA’s TA Score: 3 bullish, 6 bearish.
  • OGEN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, OGEN is a better buy in the short-term than ATHA.

Price Growth

ATHA (@Biotechnology) experienced а -1.52% price change this week, while OGEN (@Biotechnology) price change was +7.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

ATHA is expected to report earnings on Mar 20, 2025.

OGEN is expected to report earnings on May 15, 2023.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATHA($22.3M) has a higher market cap than OGEN($4.35M). ATHA YTD gains are higher at: -76.296 vs. OGEN (-93.687). OGEN has higher annual earnings (EBITDA): -19.94M vs. ATHA (-110.88M). ATHA has more cash in the bank: 68.9M vs. OGEN (3.14M). OGEN has less debt than ATHA: OGEN (519K) vs ATHA (1.31M). ATHA (0) and OGEN (0) have equivalent revenues.
ATHAOGENATHA / OGEN
Capitalization22.3M4.35M513%
EBITDA-110.88M-19.94M556%
Gain YTD-76.296-93.68781%
P/E RatioN/AN/A-
Revenue00-
Total Cash68.9M3.14M2,191%
Total Debt1.31M519K253%
FUNDAMENTALS RATINGS
OGEN: Fundamental Ratings
OGEN
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATHAOGEN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 12 days ago
86%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
83%
N/A
View a ticker or compare two or three
Ad is loading...
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNDY242.4917.80
+7.92%
monday.com Ltd
HTZ3.420.15
+4.59%
Hertz Global Holdings
ECBK15.050.13
+0.87%
ECB Bancorp
RGR34.93-0.30
-0.85%
Sturm Ruger & Company
TPET1.11-0.36
-24.49%
Trio Petroleum Corp

ATHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHA has been loosely correlated with ALNY. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHA jumps, then ALNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHA
1D Price
Change %
ATHA100%
+5.11%
ALNY - ATHA
35%
Loosely correlated
+2.75%
OGEN - ATHA
33%
Loosely correlated
-5.53%
PCVX - ATHA
33%
Poorly correlated
+0.37%
MNKD - ATHA
32%
Poorly correlated
+8.73%
SNGX - ATHA
31%
Poorly correlated
-4.22%
More

OGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGEN has been loosely correlated with ATHA. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if OGEN jumps, then ATHA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGEN
1D Price
Change %
OGEN100%
-5.53%
ATHA - OGEN
33%
Loosely correlated
+5.11%
SRPT - OGEN
30%
Poorly correlated
-0.42%
CHRS - OGEN
27%
Poorly correlated
+2.70%
RNA - OGEN
26%
Poorly correlated
+2.48%
FBRX - OGEN
25%
Poorly correlated
+3.64%
More